Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001092618 | SCV001249200 | pathogenic | not provided | 2019-11-01 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001784643 | SCV002022212 | pathogenic | Multiple acyl-CoA dehydrogenase deficiency | 2021-10-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001784643 | SCV003442985 | pathogenic | Multiple acyl-CoA dehydrogenase deficiency | 2022-01-12 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 872253). This variant is also known as c.12_22dup. This premature translational stop signal has been observed in individual(s) with multiple acyl-CoA dehydrogenase deficiency (PMID: 16510302). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change creates a premature translational stop signal (p.Gln9Argfs*20) in the ETFA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ETFA are known to be pathogenic (PMID: 16510302, 23785301). |
Baylor Genetics | RCV001784643 | SCV004194740 | pathogenic | Multiple acyl-CoA dehydrogenase deficiency | 2024-02-16 | criteria provided, single submitter | clinical testing |